HRMY

Harmony Biosciences Holdings, Inc.

33.99 USD
+0.67 (+2.01%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Harmony Biosciences Holdings, Inc. stock is up 15.42% since 30 days ago. The next earnings date is Jul 30, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 July’s closed higher than June. 100% of analysts rate it a buy.

About Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. develops and commercializes therapies for patients with rare neurological disorders in the United States. WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.

  • Needham
    Tue Jun 25, 05:28
    buy
    confirm
  • Needham
    Mon Jun 24, 13:00
    buy
    confirm
  • Citigroup
    Fri Jun 21, 10:25
    buy
    initial